Webinar Date: January 28-30 (see the schedule for specific webinar times)
Activity Dates: 01/28/2020 - 06/30/2025
CPNP Communities Week is a 3-day virtual event, exclusively for CPNP members! This event will feature webinars from each of the CPNP communities on the relevant topics listed in the schedule below. This exciting event replaces the Lunch and Learn Webinars from prior years with a more concentrated opportunity to learn and network with your peers in CPNP. These community activities focus on extremely relevant, current issues in practice and are designed to foster discussion during the calls. 1.0 contact hours of ACPE credit is provided only for select webinars. Please see the schedule for more information.
CPNP Communities Week is free to attend, and CPNP members only need to register once for the full 3-day event. Registrants may attend as many webinars as desired, and all webinar recordings will be posted following the event. Register today!
The Patient Medication Education Group (PMEG) Community is hosting a webinar on the topic of how to provide and structure inpatient psychiatric patient medication education groups. During the webinar we will be focusing on 1) initiation and structure of PMEGs, 2) topics incorporated, 3) how to engage patients, 4) resources to provide to patients, and 5) how to incorporate pharmacy learners into the groups. Speaker Dr. Andria Church provides inpatient psychiatric groups at her practice site, JFK Medical Center – North Campus (West Palm Beach, FL). Andria Church (PharmD, BCPS, BCPP) is an Assistant Professor of Pharmacy Practice at Palm Beach Atlantic University’s Lloyd L. Gregory School of Pharmacy. She is a psychiatric pharmacist and as part of her faculty appointment has a practice site within the inpatient psychiatric units at the aforementioned JFK North.
Speaker: Andria F. Church, PharmD, BCPS, BCPP, Assistant Professor of Pharmacy Practice, Lloyd L. Gregory School of Pharmacy – Palm Beach Atlantic University
Presented by the Patient Medication Education Groups (PMEG) Community
The Patient Care Practice Management Community is hosting a webinar regarding the recent Professional Affairs pharmacist survey. During the webinar we will be focusing on some of the data collected by the survey and how it might be used to help advance the practice of psychiatric pharmacy. Speakers Carla Cobb, PharmD, BCPP and Richard Silvia, PharmD, BCPP are the current chair and vice-chair of the Professional Affairs Committee, and both have extensive clinical practice experience in psychiatric pharmacy as well as academia.
Speakers: Carla Cobb, PharmD, BCPP, Clinical Pharmacist, Founder and Consultant, Capita Consulting PLLC, Billings, MT and Richard Silvia, PharmD, BCPP, Associate Professor of Pharmacy Practice, MCPHS University, Boston, MA
Presented by the Patient Care Practice Management (PCPM) Community
Clinician burnout can negatively affect patient care. Additionally, stress and poor well-being can lead to mental health issues such as depression, substance abuse and suicide. Although burnout can occur at any stage in one’s career, stress during post-graduate training can be significant and may lead to burnout and poor well-being. Residency programs should educate preceptors and residents about burnout to promote well-being and potentially increase resident resiliency. At the conclusion of this seminar, residency program directors should be able to define resident well-being, identify methods for assessing burnout and well-being and implement a well-being plan for their program.
Speakers: Kelly Lee, PharmD, MAS, BCPSS, FCCP, Professor of Clinical Pharmacy, University of California, San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, Elayne Ansara, PharmD, BCPS, BCPP, Clinical Pharmacy Specialist, Richard L. Roudebush VAMC, and M. Lindsey Hedgepeth Kennedy, PharmD, BCPS, BCPP, Psychiatry Clinical Specialist, UNC Hospitals
Presented by the Residency Program Directors Community
The Child and Adolescent Psychiatry (CAP) Community is hosting a webinar on the role of long acting injectable antipsychotics in child and adolescent psychiatry. During the webinar we will review current literature/guidelines, clinical considerations when choosing long acting injectable antipsychotics, and considerations for institution-specific guidelines.
Danielle Stutzman PharmD, BCPP is a psychiatric pharmacist at Children’s Hospital Colorado’s Pediatric Mental Health Institute. Sandra Mullen PharmD, BCPP is a psychiatric pharmacist at Virginia Commonwealth University Health System. Off-label use of antipsychotics will be discussed. Speakers have no other relevant disclosures.
Speakers: Danielle Stutzman PharmD, BCPP, Psychiatric Pharmacist, Children’s Hospital Colorado’s Pediatric Mental Health Institute and Sandra Mullen PharmD, BCPP, Psychiatric Pharmacist, Virginia Commonwealth University Health System
Presented by the Child and Adolescent Psychiatry Community
There is currently no cure or proven disease modifying treatment, and only palliative treatment is available for management of motor and non-motor symptoms. Motor complications are important aspects associated with a long-term carbidopa/levodopa therapy and advanced Parkinson disease (PD). These complications, especially unpredictable “off” periods/freezing and dyskinesia, are difficult to manage and can have a significant impact on quality of life. In recent years, symptomatic therapies were approved or are currently being evaluated for approval. This webinar will concentrate on management strategies of motor fluctuations and psychotic symptoms. Emphasis will be given to novel therapies including new medication classes, and improved drug delivery of dopaminergic therapy including wearable devices. In addition, update on select drug targets for disease modifying therapy in PD will be covered. This program aims to provide information regarding management of motor symptoms and complications in PD with emphasis on newly-approved medications/formulations. It is crucial that the clinicians be knowledgeable about new strategies to promote optimal quality of life for those suffering from PD to provide high-quality PD care, counseling and education.
Learning Objectives:
Speaker: Marketa Marvanova PharmD, PhD, BCGP, BCPP, FASCP, Professor and Chair, Department of Pharmacy Practice, NDSU School of Pharmacy
Presented by the Geriatric Community
The Teaching Community is hosting a webinar on innovative teaching methodology related psychiatric content and/or patient cases. During the webinar, we will be focusing on creative and innovative approaches to teaching neurologic and psychiatric pharmacy pharmacotherapy courses and inclusion of real-life patient cases to enhance student learning and retention. Speaker Dr. Sarah Melton coordinates the 6-credit-hour Integrated Course on Neurologic and Psychiatric Pharmacy and an Addiction in Appalachia Elective course at the East Tennessee State University Gatton College of Pharmacy. Dr. Melton serves as the clinical pharmacist at the Johnson City Community Health Center and the ETSU Center of Excellence for HIV/AIDS Care. Dr. Melton received her Bachelor of Science in Pharmacy (1991) and Doctor of Pharmacy (1994) degrees from Virginia Commonwealth University/Medical College of Virginia School of Pharmacy (VCU). She completed a Fellowship in Psychiatric Pharmacy at VCU in 1996. She has been a board-certified psychiatric pharmacist (Board of Pharmaceutical Specialties) since 1997 and a board-certified ambulatory care pharmacist since 2011. She is a Fellow of the American Society of Consultant Pharmacists. She performs comprehensive medication management in the areas of psychiatric and neurologic pharmacy, substance use disorders, and other primary care disorders.
Speaker: Sarah T. Melton, PharmD, BCPP, BCACP, FASCP, Professor of Pharmacy Practice, East Tennessee University Gatton College of Pharmacy
Presented by the Teaching Community
In today’s practice environment, pharmacists and pharmacy students may encounter situations in which they need to discuss sensitive topics, such as suicide, with patients. But are we currently preparing pharmacists and students to effectively engage patients in these sensitive discussions? In this webinar, participants will view and evaluate materials, such as videos and role plays that are currently being used to teach pharmacists and pharmacy students how to communicate about suicide. Delesha Carpenter, MSPH, PhD, is an Associate Professor in the Division of Pharmaceutical Outcomes and Policy at the Eshelman School of Pharmacy at the University of North Carolina at Chapel Hill. Her educational background includes clinical training in respiratory therapy and public health. She has over ten years of experience working on patient-provider communication projects. She has authored more than 90 peer-reviewed publications and has led more than a dozen research studies as a principal investigator. Dr. Carpenter has received funding from the Department of Veterans Affairs (VA) Center of Excellence for Suicide Prevention and the VA Office of Mental Health & Suicide Prevention to understand pharmacy staff’s preferences for suicide prevention education.
Speaker: Delesha Miller Carpenter, PhD, MSPH, Associate Professor, UNC Eshelman School of Pharmacy
Presented by the Teaching Community
The research community is hosting a webinar on the topic of the role of the IRB in your research. Participants will learn the role of the IRB along with the review process associated with IRB approval. In addition, participants will learn what research/projects need approval and the importance of the IRB as a resource for your research.
Speaker: Lynda J. Dimitroff, PhD, MSEd, BSN, MCHES, Chairperson IRB, Rochester Regional Health
Presented by the Research Community
The Substance Use Disorders (SUD) Community is hosting a webinar on the topic of ibogaine for detoxification and management of Opioid Use Disorder (OUD). Ibogaine is a psychedelic drug touted for its unique and robust ability to detoxify persons physically & psychologically dependent on opioids. However, ibogaine is regulated as an illicit substance in the United states and is associated with prolongation of the QTc interval, ventricular arrhythmias, and cardiac death. During the webinar, speaker Benjamin Malcolm, PharmD, MPH, BCPP will focus on the rationale for the research and development of ibogaine, the emerging role of spiritual drug experience in the treatment of mental illness and SUDs, the pharmacology of ibogaine, and existing clinical data on ibogaine for OUD.
Speaker: Benjamin Malcolm, PharmD, MPH, BCPP, Assistant Professor of Pharmacy Practice and Administration, Western University of Health Sciences College of Pharmacy
Presented by the Substance Use Disorders Strategies (SUDS) Community
Communities Week offer member-driven activities intended to facilitate dialogue among psychiatric pharmacy professionals. While presenters are encouraged to disclose any conflicts and to use the best evidence available, only the presentations offering ACPE credit are peer reviewed and attendees should accordingly verify details prior to making significant practice changes.
AAPP has invested in supporting the most popular web browsers and leveraging software that our members use daily. Beyond PDF downloads, the rest of the system is built on HTML5, a technology that most up-to-date browsers will support. To access AAPP course materials online, you will need:
AAPP web sites no longer fully support Microsoft Internet Explorer or Windows 8.1 and older. We cannot guarantee that the site will function perfectly on every device and configuration, but using the latest version of the software above will greatly improve your experience.
AAPP owns the copyright, is licensed or has received permissions for use of, or is otherwise permitted to use copyrighted materials within any CPE activity. Authors and speakers are required to obtain necessary copyright permissions for content in CPE activities. AAPP complies with copyright laws and regulations.